Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

High risk drugs > sodium valproate + lithium > Flashcards

sodium valproate + lithium Flashcards

1
Q

what is the only indication where a female may be allowed to take sodium valproate during pregnancy

A

Epilepsy

  • Use of valproate in pregnancy is contra-indicated for migraine prophylaxis [unlicensed] and bipolar disorder; it must only be considered for epilepsy if there is no suitable alternative treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

when dispensing a sodium valproate prescription for a female, how often should the pharmacist discuss the risks in pregnancy

A

each time valproate medicines are dispensed

  • also ensure they have a patient card
  • note pharmacist also need to ensure they have the Patient Guide and have seen their GP or specialist to discuss their treatment and the need for contraception. but this is not everytime valproate is dispensed*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how often do female patients taking sodium valproate need to be reviewed by a specialist

A

annually

note review ensures women are on pregnancy prevention programme (PPP) and re-evaluates to see if treatment is necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the contraindications for sodium valproate

A
  • Acute porphyrias (liver disorder which causes porphyrins to build up in the liver. There are different types but acute porphyrias affects the nervous system)
  • known or suspected mitochondrial disorders (higher rate of acute liver failure and liver-related deaths)
  • personal or family history of severe hepatic dysfunction
  • urea cycle disorders (risk of hyperammonaemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Although raised liver enzymes during valproate treatment are usually short term, how long should you monitor liver function for

A
  • reassessed clinically and liver function (including prothrombin time) monitored until results return to normal
  • discontinue if abnormally prolonged prothrombin time (particularly in association with other relevant abnormalities))
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what should you do if a patient taking sodium valproate has a prolonged prothrombin time

A

discontinue treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

name some common side effects of sodium valproate

A
  • hepatic disorders
  • hypersensitivity
  • hyponatremia
  • Abdominal pain
  • agitation
  • alopecia (regrowth may be curly)
  • abnormal behaviour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which symptoms indicate you need to withdraw sodium valproate treatment immediately

A

Withdraw treatment immediately if persistent vomiting and abdominal pain, anorexia, jaundice, oedema, malaise, drowsiness, or loss of seizure control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what should you do if a patient taking sodium valproate starts to show symptoms of pancreatitis

name some symptoms of pancreatits

A

discontinue treatment

symptoms of pancreatitis:

  • suddenly getting severe pain in the centre of your tummy (abdomen)
  • feeling or being sick
  • diarrhoea
  • a high temperature of 38C or more (fever)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

if sodium valproate is used during pregnancy, describe how the doses should be given

A
  • the lowest effective dose should be prescribed in divided doses or as modified-release tablets to avoid peaks in plasma-valproate concentrations
  • doses greater than 1 g daily are associated with an increased risk of teratogenicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how do you avoid peaks in plasma-valproate concentrations in pregnant women taking sodium valproate

A

the lowest effective dose should be prescribed in divided doses or as modified-release tablets to avoid peaks in plasma-valproate concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the risk associated with breastfeeding whilst taking sodium valproate

A

sodium valproate is present in milk—risk of haematological disorders in breast-fed newborns and infants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

TRUE OR FALSE

it is advised to avoid sodium valproate in hepatic impairement

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

why is routine monitoring of the Plasma-valproate concentrations unhelpful

A

Plasma-valproate concentrations are not a useful index of efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what monitoring should occur for patients taking sodium valproate

A
  • Monitor liver function before therapy and during first 6 months especially in patients most at risk
  • Measure full blood count and ensure no undue potential for bleeding before starting and before surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how do you withdraw sodium valproate treatment

A

Avoid abrupt withdrawal; if treatment with valproate is stopped, reduce the dose gradually over at least 4 weeks

17
Q

do patients taking sodium valproate need to be given the same/specific manufacturers brand

A

sodium valproate = stage 2 so whether or not a patients needs a specific manufacturer is:

based on clinical judgement and consultation with the patient or their carer, taking into account factors such as seizure frequency and treatment history.

18
Q

when should patients taking sodium valproate seek immediate medical attention

A

if they develop symptoms of:

  • blood disorders (fever, infections, fatigue, abnormal bleeding)
  • liver disorders (jaundice, dark urine, tenderness/pain in liver area, nausea + vomiting, pale colour stool or very dark stools)
  • pancreatitis such as abdominal pain, nausea, or vomiting develop
19
Q

TRUE OR FALSE

preparations of lithium are dose equivalent

A

FALSE

Preparations of lithium vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment

20
Q

name the contraindications for lithium

A
  • Addison’s disease (reduced cortisol/ aldosterone due to faulty adrenal glands)
  • cardiac insufficiency
  • dehydration
  • low sodium diets
  • untreated hypothyroidism
21
Q

what are the risks associated with long term use of lithium

A
  • Long-term use of lithium has been associated with thyroid disorders and mild cognitive and memory impairment.

Monitor thyroid function every 6 months (more often if there is evidence of deterioration).

22
Q

name some of the symptoms of lithium toxicity

A
  • increasing GI disturbances (vomiting, diarrhoea)
  • visual disturbances
  • polyuria (excess urine production), incontinence (partial or complete loss of bladder control)
  • fine tremor increasing to coarse tremor
  • CNS disturbances (confusion and drowsiness increasing to lack of coordination, restlessness, stupor);
  • myoclonus (involuntary muscle jerks),

if there is a severe overdose symptoms are:

  • cardiac arrhythmias (including sinoatrial block, bradycardia and first-degree heart block)
  • renal failure
  • coma and sudden death reported
23
Q

TRUE OR FALSE

women of child-bearing age taking lithium MUST be on contraception

A

FALSE

effective contraception is advised but not mandatory

24
Q

describe how lithium treatment is managed in pregnant women

A
  • Avoid if possible, particularly in the first trimester (risk of teratogenicity, including cardiac abnormalities)
  • Dose requirements increased during the second and third trimesters (but on delivery return abruptly to normal)
  • ensure close monitoring of serum-lithium concentration in pregnancy
25
Q

which trimester should pregnant women avoid taking lithium and why

A

avoid taking lithium in the first trimester because there is a risk of teratogenicity including cardiac abnormalities

26
Q

why should women avoid breastfeeding whilst taking lithium

A

because lithium is present in breast milk so there is a risk of toxicity to the infant

27
Q

what monitoring should occur for patients taking lithium

A
  • body-weight or BMI
  • serum electrolytes
  • serum-lithium monitoring
  • eGFR and thyroid function every 6 months
28
Q

describe how to withdraw lithium treatment

A
  • the dose should be reduced gradually over a period of at least 4 weeks (preferably over a period of up to 3 months). This is because abrupt withdrawal increases risk of relapse
  • if lithium is stopped abruptly, consider changing therapy to an atypical antipsychotic or valproate.
29
Q

why should patients taking lithium maintain adequate fluid intake and avoid dietary changes

A

because changing your diet or not having enough fluid intake can increase or decrease sodium levels intake. Low sodium diets are contraindicated for lithium

30
Q

what signs and symptoms should you advise patients to report whilst taking lithium

A

report signs and symptoms of:

  • lithium toxicity
  • hypothyroidism
    renal dysfunction (including polyuria - excess urine production and polydipsia- excessive thirst)
  • benign intracranial hypertension (persistent headache and visual disturbance).
31
Q

what is the therapeutic range of serum-lithium concentration

A

ideal serum-lithium concentration of 0.4–1 mmol/litre

lower end of the range for maintenance therapy and elderly patients

32
Q

what is lithium used for (indications)

A

Treatment/prophylaxis of mania, bipolar disorder, recurrent depression, aggressive or self-
harming behaviour

High risk drugs (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions